Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction.
暂无分享,去创建一个
H. Reichenspurner | T. Meinertz | J. Schofer | M. Schlüter | V. Rudolph | S. Baldus | O. Franzen | H. Treede | D. Koschyk | A. Barmeyer | M. Knap | S. Meyer | A. Costard-Jäckle | H. Reichenspurner
[1] Scott Lim,et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. , 2009, Journal of the American College of Cardiology.
[2] S. Goldberg,et al. Percutaneous Mitral Annuloplasty for Functional Mitral Regurgitation: Results of the CARILLON Mitral Annuloplasty Device European Union Study , 2009, Circulation.
[3] R. Wynne,et al. Long-term patency of 1108 radial arterial-coronary angiograms over 10 years. , 2009, The Annals of thoracic surgery.
[4] Sean M. O'Brien,et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. , 2009, The Annals of thoracic surgery.
[5] O. Alfieri,et al. Long‐term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction , 2009, European journal of heart failure.
[6] M. Buchbinder,et al. Percutaneous suture edge-to-edge repair of the mitral valve. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] J. Chambers,et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[8] Michael Böhm,et al. Kommentar zu den ESC-Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 , 2008, European journal of heart failure.
[9] E. Foster,et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. , 2007, The American journal of cardiology.
[10] Alec Vahanian,et al. Valvular heart disease in the community: a European experience. , 2007, Current problems in cardiology.
[11] Randolph P. Martin,et al. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[12] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[13] J. Harnek,et al. Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With Device Implantation in the Coronary Sinus , 2006, Circulation.
[14] S. Mittal,et al. Coapsys mitral annuloplasty for chronic functional ischemic mitral regurgitation: 1-year results. , 2006, The Annals of thoracic surgery.
[15] 黄亚明,et al. European Society of Intensive Care Medicine , 2005, Intensive Care Medicine.
[16] E. Foster,et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. , 2005, Journal of the American College of Cardiology.
[17] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] D. M. Gangahar,et al. Intraoperative effects of the coapsys annuloplasty system in a randomized evaluation (RESTOR-MV) of functional ischemic mitral regurgitation. , 2005, The Annals of thoracic surgery.
[19] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[20] W. Edwards,et al. Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. , 2004, Journal of the American College of Cardiology.
[21] Natesa G Pandian,et al. Percutaneous mitral valve repair: A feasibility study in an ovine model of acute ischemic mitral regurgitation , 2003, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[22] D. Kaye,et al. Feasibility and Short-Term Efficacy of Percutaneous Mitral Annular Reduction for the Therapy of Heart Failure-Induced Mitral Regurgitation , 2003, Circulation.
[23] R. Levine,et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. , 2003, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[24] Andreas Franke,et al. Acute effects of cardiac resynchronization therapy on functional mitral regurgitation in advanced systolic heart failure. , 2003, Journal of the American College of Cardiology.
[25] C. O'connor,et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. , 2003, The American journal of cardiology.
[26] O. Alfieri,et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. , 2001, The Journal of thoracic and cardiovascular surgery.
[27] S. Lemeshow,et al. European system for cardiac operative risk evaluation (EuroSCORE). , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[28] F. Grover,et al. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of The Society of Thoracic Surgeons. , 1999, The Annals of thoracic surgery.
[29] J B Seward,et al. Clinical outcome of mitral regurgitation due to flail leaflet. , 1996, The New England journal of medicine.
[30] W. Gaasch,et al. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. , 1996, Journal of the American College of Cardiology.
[31] P. Kligfield,et al. Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance. , 1994, The American journal of cardiology.